Navigation Links
Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
Date:9/22/2008

Live Audio Webcast Thursday, September 25, 2008

SAN DIEGO, Sept. 22 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences will be presenting at the UBS Global Life Sciences Conference at the Grand Hyatt in New York.

The live presentation takes place Thursday, September 25, 2008 at 10:00 a.m. Eastern Time (ET) /7:00 a.m. Pacific Time (PT). The presentation will be simultaneously webcast and may be accessed on the Company's website at http://www.neurocrine.com which will link you to the UBS Conference site. Once you have been linked to their site, you have the option to search by company name, or by time and date to access the webcast.

If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. A replay of the presentation will be available approximately three hours after the conclusion of the live event and will be archived on the website for two weeks.

About Neurocrine

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome (IBS), anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH) and other neurological and endocrine related diseases and disor
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference
2. Neurocrine Biosciences Reports Second Quarter 2008 Results
3. Neurocrine Biosciences Announces Conference Call and Webcast To Present Second Quarter 2008 Financial Results
4. Neurocrine Biosciences to Present at the 2008 Citi Investment Research Global Health Care Conference
5. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2008 Financial Results
6. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2007 Financial Results
7. Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer
8. Neurocrine Announces Work Force Restructuring
9. Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
10. Neurocrine Biosciences Announces Conference Call and Webcast to Provide Indiplon Update
11. Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...if., Nov. 6 Intarcia Therapeutics,...A 650 (DUROS® continuous delivery of exenatid... the Ninth Annual Diabetes Technology Meeting in S....com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,, C...TCA 650 Lowers Plasma Glucose, HbA1c and Reduces W...
(Date:11/5/2009)...Colo., Nov. 5 The endangered black...estern U.S. This rare carnivore feeds on prairie ...lague and often entire population die-offs in town...S) has implemented a ferret breeding program and h...eir formerly native habitat. Unfortunately, plagu...
(Date:11/5/2009)...all on Thursday, November 5, 2009 at 4:30 p.m. Eas.../PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals...XI ) today reported unaudited financial results fo...r 30, 2009 and reviewed the Company,s highlights f...consolidated results reflect the operations of Onc...
(Date:11/5/2009)...Texas, Nov. 5 Wound Mana... that it has entered into a Letter of Intent to pu...alth Technologies, Inc. (OTC Bulletin Board: VHGI)... in cash and debt, 4,000,000 shares of WNDM and a ...n the Veriscrip technology being acquired from VHG...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3
... Michael Bruns brings extensive...panding Chicago-based clinical software company; w...ization as well as manage the company,s financial...L (PRWEB) March 19, 2009 -- ClearTrial ( www.clear...software for clinical trial operations planning, b...
...NG, Mich., March 19 Neogen Corporation (Nasdaq: ...ed by the declining global economy, its third quar...d third quarter for the 26-year-old company, compa... nine-month revenues rose 17% in the current fisca... , , Year-to-date net income for the first nin...
...ntments Strengthen Expertise in Immunotherapy of C... (Nasdaq: MITI ), a biopharmaceutical company de...atment of cancer, inflammation and autoimmune dise...alter Bodmer and Bernard Fox to its BiTE antibody ...isory panel include professors Richard Flavell ( Y...
Other Biology Technology:ClearTrial Names Software Industry Veteran Michael Bruns as Chief Operating Officer 2ClearTrial Names Software Industry Veteran Michael Bruns as Chief Operating Officer 3Neogen Reports Record Third Quarter 2Neogen Reports Record Third Quarter 3Neogen Reports Record Third Quarter 4Neogen Reports Record Third Quarter 5Neogen Reports Record Third Quarter 6Micromet Adds Sir Walter Bodmer and Bernard Fox to Its Advisory Panel for BiTE Antibody Therapeutics 2Micromet Adds Sir Walter Bodmer and Bernard Fox to Its Advisory Panel for BiTE Antibody Therapeutics 3Micromet Adds Sir Walter Bodmer and Bernard Fox to Its Advisory Panel for BiTE Antibody Therapeutics 4Micromet Adds Sir Walter Bodmer and Bernard Fox to Its Advisory Panel for BiTE Antibody Therapeutics 5
(Date:11/6/2009)...open for the Society of Interventional Radiology,s...ies" Webinar, which will provide the latest update...iver tumors, kidney tumor ablation and lung tumor ...ians, scientists and allied health professionals d...ring advances in image-guided therapy. , The Web...
(Date:11/6/2009)... -- Auburn Hills, MI-based Law Enforcement Intelli...cker system and patent-pending Biometric Access Co...Health and Human Services, National Institutes of ...stem will support the NIH,s entire police force th...cal research agency. The project is expected to b...
(Date:11/5/2009)...ale University have developed synthetic molecules ... HIV and HIV-infected cells, as well as to prostat...n the Journal of the American Chemical Society , ...se diseases. , The molecules called "antibody-...tibody-recruiting molecule targeting prostate canc...
Breaking Biology News(10 mins):Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2New synthetic molecules trigger immune response to HIV and prostate cancer 2Millin Associates has the Perfect Solution for Hospitals 26 Health Centers Dealing With an Influx of Uninsured Patients 53540 1Millin Associates has the Perfect Solution for Hospitals 26 Health Centers Dealing With an Influx of Uninsured Patients 53540 2One in 10 High School Seniors Have Used Narcotic Painkillers 53538 1One in 10 High School Seniors Have Used Narcotic Painkillers 53538 2One in 10 High School Seniors Have Used Narcotic Painkillers 53538 3Boston Scientific to Participate in BMO Capital Markets Health Care Conference 53533 1
...ion among chimpanzees has found that the tradition...opulations—western, central and eastern—is underpi...ree times greater than the variation between the m...007 issue of the journal PLOS Genetics, researcher...ad Institute and Arizona State show that there has...
...s multiple sclerosis (MS) has been noted in recent...ause of this increase. One theory, similar to the ...free environment may contribute to an increase in ...ases may play a role in increasing autoimmune dise...ionship between parasite infections and MS in huma...
...ammatory disorder of the intestinal tract that aff... world. Common symptoms include abdominal pain and...th debilitating clinical complications. Researcher...uncovered an important clue to the susceptibility ... association study with more than 300,000 single n...
Other Biology News:Gene study shows three distinct groups of chimpanzees 2Parasite infection may benefit MS patients 2
Endotoxin Free Water from Mo Bio Laboratories, Inc.
Chicken Anti-GBL Polyclonal Antibody, Unconjugated from ProSci, Inc
DEPC water from Mo Bio Laboratories, Inc.
Chicken Anti-TLN2 Polyclonal Antibody, Unconjugated from ProSci, Inc
Biology Products: